Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Infection and Immunity
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
MOLECULAR AND CELLULAR PATHOGENESIS

Coxiella burnetii Survives in Monocytes from Patients with Q Fever Endocarditis: Involvement of Tumor Necrosis Factor

Jérôme Dellacasagrande, Eric Ghigo, Christian Capo, Didier Raoult, Jean-Louis Mege
Jérôme Dellacasagrande
Unité des Rickettsies, Universitéde la Méditerranée, CNRS UPRESA 6020, Faculté de Médecine, 13385 Marseille Cedex 05, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Ghigo
Unité des Rickettsies, Universitéde la Méditerranée, CNRS UPRESA 6020, Faculté de Médecine, 13385 Marseille Cedex 05, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Capo
Unité des Rickettsies, Universitéde la Méditerranée, CNRS UPRESA 6020, Faculté de Médecine, 13385 Marseille Cedex 05, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Didier Raoult
Unité des Rickettsies, Universitéde la Méditerranée, CNRS UPRESA 6020, Faculté de Médecine, 13385 Marseille Cedex 05, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Louis Mege
Unité des Rickettsies, Universitéde la Méditerranée, CNRS UPRESA 6020, Faculté de Médecine, 13385 Marseille Cedex 05, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/IAI.68.1.160-164.2000
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Endocarditis is the most frequent form of chronic Q fever, an infectious disease caused by Coxiella burnetii. As this obligate intracellular bacterium inhabits monocytes and macrophages, we wondered if pathogenesis of Q fever endocarditis is related to defective intracellular killing of C. burnetii by monocytes. Monocytes from healthy controls eliminated virulent C. burnetii within 3 days. In contrast, monocytes from patients with ongoing Q fever endocarditis were unable to eliminate bacteria even after 6 days. In patients who were cured of endocarditis, the monocyte infection was close to that of control monocytes. This killing deficiency was not the consequence of generalized functional impairment, since patient monocytes eliminated avirulent C. burnetii as did control cells. The addition of supernatants ofC. burnetii-stimulated monocytes from patients with ongoing endocarditis to control monocytes enabled them to support C. burnetii survival, suggesting that some soluble factor is responsible for bacterial survival. This factor was related to tumor necrosis factor (TNF): expression of TNF mRNA and TNF release were increased in response to C. burnetii in patients with ongoing endocarditis compared to cured patients and healthy controls. In addition, neutralizing anti-TNF antibodies decreased C. burnetii internalization, an early step of bacterial killing, in monocytes from patients with ongoing endocarditis but did not affect delayed steps of intracellular killing. We suggest that Q fever-associated activation of monocytes allows the survival ofC. burnetii by modulating early phases of microbial killing.

Q fever is caused by Coxiella burnetii, an obligate intracellular bacterium inhabiting monocytes and macrophages (1). The disease exhibits acute and chronic forms with different courses. Endocarditis is the most frequent clinical expression of chronic Q fever (23). Q fever endocarditis usually occurs in patients with valvular disease and/or alterations in cell-mediated immunity, such as infection by human immunodeficiency virus, lymphoma, chronic renal failure, or pregnancy (21). The medical treatment of endocarditis is long, even when antibiotics are used with chloroquine (24). The evaluation of its efficiency requires prolonged follow-up because of the possibility of late relapses (22).

Macrophages exhibit microbicidal activity which involves binding and phagocytosis of microorganisms and the action of oxidative and nonoxidative compounds within phagocytic vacuoles. Macrophage-mediated killing of microorganisms also requires T-cell-derived cytokines, including gamma interferon (IFN-γ) (25). Hence, patients with IFN-γ receptor deficiency exhibit increased occurrences of mycobacterial infections (2). Conversely, cytokines which down-modulate microbicidal activity of macrophages favor the survival of intracellular microorganisms (3). The survival strategy of C. burnetii should interfere with the intrinsic microbicidal activity of macrophages and/or its regulation. Patients with Q fever endocarditis exhibit impaired cell-mediated immunity, including antigen-driven lymphoproliferation (17) and IFN-γ production (14). We recently demonstrated that IFN-γ induces C. burnetii killing via apoptosis of infected macrophages (10). The suppression of T-cell responses to C. burnetii depends on the release of soluble mediators such as prostaglandins (18) or interleukin-10 (IL-10) (6) by monocytes. Beside their suppressive role, monocytes from patients with Q fever endocarditis overproduce tumor necrosis factor (TNF), a proinflammatory cytokine (5). This may be related to the specific inflammatory syndrome of Q fever endocarditis, consisting of an increase in circulating TNF without variations in cytokine antagonists (7).

This study was undertaken to assess the survival of C. burnetii in monocytes from patients with Q fever endocarditis. Control monocytes eliminated C. burnetii, whereas those of patients with ongoing Q fever endocarditis did not. This defect was not intrinsic but was related to an increase in TNF production. TNF was involved in this defect mainly by upregulating C. burnetii internalization. We suggest that the level of monocyte activation in Q fever determines the survival of C. burnetii.

MATERIALS AND METHODS

Patients.Twenty patients, consisting of 13 males and 7 females (mean age, 59 years; range, 39 to 79 years), were included in the study. The diagnosis of endocarditis was based on modified Duke endocarditis service criteria (11). Patients had pathological evidence of endocarditis, a positive echocardiogram, positive blood culture, and high titers of immunoglobulin G (IgG) directed against C. burnetii. All of these patients were subjected to valve replacement and medical treatment with doxycycline and chloroquine. They were divided in two groups: one consisting of patients with ongoing endocarditis (n = 10) characterized by high titers of specific IgG (mean, 21,000; range, 1,600 to 120,000) and the other made up of patients recently cured of the disease (n = 10) and who had low antibody titers (mean, 600; range, 400 to 800). The first group was treated during the course of the study, while treatment of the second group had been stopped at least 3 months before the investigation. Ten healthy subjects, sex and age matched, were included in the study as controls.

Monocytes and bacteria.Blood was drawn in EDTA-anticoagulated tubes, and peripheral blood mononuclear cells were separated with Ficoll gradients (Eurobio, Les Ulis, France). Cells were suspended in RPMI 1640 containing 20 mM HEPES (Gibco-BRL, Life Technologies, Cergy-Pontoise, France), 10% fetal calf serum (FCS), 2 mM l-glutamine, 100 U of penicillin per ml, and 100 μg of streptomycin (Gibco-BRL) per ml. Monocytes were purified by incubating 5 × 105 peripheral blood mononuclear cells in a glass Labtek chamber/slide (Miles, Naperville, Ill.) for 60 min at 37°C. Nonadherent cells were removed by washing, and the remaining cells were designated monocytes because more than 90% of them were CD14+ and had phagocytic characteristics (5).

Virulent C. burnetii (Nine Mile strain in phase I; ATTC VR-615) was injected into mice and 10 days later was recovered from spleens and then cultured in mouse L929 fibroblasts maintained in antibiotic-free minimal essential medium (Gibco-BRL) supplemented with 4% FCS and 2 mM l-glutamine for two passages. Avirulent variants were obtained by repeated passages of Nine Mile strain in L929 cells (20). After 1 week, L929 cells were sonicated, and the homogenates were centrifuged at 5,000 × g for 10 min. The bacterial pellet was layered on a 25 to 45% linear Renografin gradient and spun down. Purified bacteria were then collected, washed, and suspended in serum-free medium before being stored at −80°C. The concentration of C. burnetii was determined by Gimenez staining.

Infection procedure.Monocytes were incubated with C. burnetii in phase I (bacterium-to-cell ratio of 200:1) for 24 h in RPMI 1640 containing 10% FCS (10). The cells were washed to remove free bacteria (corresponding to day 0) and cultured for 6 days. As controls, monocytes were incubated with avirulentC. burnetii at a bacterium-to-cell ratio of 100:1 for 24 h. As avirulent bacteria were more efficiently internalized by monocytes than virulent organisms (8), we incubated monocytes with a lower number of avirulent C. burnetiiorganisms to obtain similar amounts of infection. In some experiments, a 10-μg/ml concentration of goat antibodies (Ab) neutralizing bioactive TNF or control IgG (R&D Systems, Abingdon, United Kingdom) was added to monocytes before C. burnetii infection. Cellular infection was quantified by Gimenez staining. Results were expressed as an infection index, as follows: (number of bacteria per infected cell) × (number of infected cells/100) × 100.

The viability of intracellular bacteria was determined as previously described (10). Briefly, infected monocytes were sonicated, and serial dilutions of homogenates were added to HEL cell monolayers.C. burnetii replication was revealed by indirect immunofluorescence with rabbit Ab directed against C. burnetii.

Cytokine determination. (i) Immunoassays.Monocytes (2 × 105 cells/assay) were incubated with C. burnetii (bacterium-to-cell ratio of 200:1) for 24 h. Supernatants were assayed for the presence of TNF and IL-6. The limits of detection of the immunoassay kits (Immunotech, Marseille, France) were 10 and 3 pg per ml, respectively.

(ii) RNA extraction and PCR amplification.Monocytes (5 × 105 cells/assay) were incubated with C. burnetii (bacterium-to-cell ratio of 200:1) for 3 h. RNA was extracted by using the guanidium-phenol chloroform method (5). cDNA was generated by incubating RNA in a reverse transcriptase mixture. cDNA specimens were amplified in the presence of primers specific for TNF or IL-6. Amplification products were quantified with CytoXpress detection kits (BioSource, Fleurus, Belgium) as previously described (4).

Statistical analysis.Results were calculated as mean ± standard error (SE). The statistical analysis was conducted by analysis of variance. Differences were considered significant when P was <0.05.

RESULTS

Killing of C. burnetii by monocytes is defective in Q fever endocarditis.Monocytes were incubated with C. burnetii in phase I for 24 h (day 0), and the infection of monocytes was assessed at days 3 and 6 postinfection (p.i.). An incubation time of 24 h was required to obtain the infection of 75% of monocytes with one to two bacteria per cell. While this initial incubation allows the measurement of the early phase of killing, the infection after 3 and 6 days is an assessment of the delayed phase of intracellular killing. At day 0, the bacterial phagocytosis in monocytes from patients with ongoing endocarditis (active patients) was different from that in monocytes from cured patients or controls (Fig.1A). The initial infection index was significantly (P < 0.005) higher in monocytes from active patients (250 ± 35) than in control monocytes (115 ± 12) or in monocytes from cured patients (136 ± 15). After 3 days, the number of bacteria was decreased by 75% in control monocytes, and only 15% of bacteria present at day 0 were found after 6 days (Fig.1B). The decrease in the bacterial count resulted from an alteration ofC. burnetii viability, as assessed by culturing homogenates from infected monocytes on HEL cells (105 ± 35 vacuoles per shell vial at day 0 and 20 ± 9 vacuoles per shell vial at day 6 for control monocytes). In contrast, the number of intact bacteria remained constant during the first 3 days p.i. and decreased slightly thereafter (15% inhibition) in monocytes from active patients. Bacterial viability was not altered after 3 days of infection (123 ± 38 vacuoles per shell vial), but it was slightly decreased at 6 days p.i. (95 ± 32 vacuoles per shell vial). In monocytes from cured patients, the number of bacteria declined by 55% after 3 days and slowly decreased thereafter (70% inhibition after 6 days). At each time, the infection index was significantly lower (P < 0.01) in monocytes from cured patients than in monocytes from active patients. We then wondered if impaired killing of C. burnetii by patient monocytes was specific. Avirulent variants ofC. burnetii were incubated with monocytes according to the procedure described for virulent bacteria. At day 0, the phagocytosis indices in control and patient cells were similar (132 ± 18 and 156 ± 24, respectively). The number of avirulent bacteria was decreased by 70% after 3 days and by 80% after 6 days in monocytes from active patients, cured patients, and healthy controls (Table1). Our results indicate that ongoing Q fever endocarditis is associated with specific defective killing of virulent C. burnetii.

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

C. burnetii survival in monocytes from patients with Q fever endocarditis. Monocytes from controls (n = 10), patients with ongoing Q fever endocarditis (active patients) (n = 10), or cured patients (n = 10) were incubated with C. burnetii at a bacterium-to-cell ratio of 200:1. Monocyte infection was determined at day 0 (A) and at 3 and 6 days p.i. (B) by Gimenez staining. In panel A, results (means ± SEs) are expressed as an infection index; in panel B, they are expressed as a relative infection index compared to values at day 0. ∗, P < 0.005; ∗∗, P < 0.01 (for the comparison of active patient values with control values).

View this table:
  • View inline
  • View popup
Table 1.

Avirulent C. burnetii killing in Q fever endocarditisa

The defect in C. burnetii killing is reproduced by supernatants from patient monocytes.We wondered if defective bacterial killing of monocytes was intrinsic or might be reproduced by soluble mediators. For that purpose, monocytes from healthy controls were treated with supernatants obtained by culturing monocytes from controls, active patients, or cured patients withC. burnetii for 24 h at 37°C. C. burnetiiwas then added to treated cells at a bacterium-to-cell ratio of 200:1, and the infection was assessed for 6 days as described above. The uptake of C. burnetii was significantly (P < 0.02) higher in cells treated with monocyte supernatants from active patients than in cells treated with control supernatants (Fig.2A). While the bacterial number steadily decreased in monocytes treated with supernatants from controls, it remained constant after 3 and 6 days in cells treated with supernatants from active patients (Fig. 2B). When monocytes were pretreated with supernatants from cured patients, the phagocytosis of C. burnetii (Fig. 2A) and the bacterial number at 3 and 6 day p.i. (Fig. 2B) were similar to those observed in cells treated with supernatants from control monocytes. Hence, monocyte supernatants from patients with ongoing endocarditis were able to induce defective intracellular killing in monocytes.

Fig. 2.
  • Open in new tab
  • Download powerpoint
Fig. 2.

Effect of monocyte supernatants on C. burnetii survival. Control monocytes were pretreated with supernatants of monocytes from healthy individuals (n = 3), active patients (n = 3) or cured patients (n = 3) which had been stimulated by C. burnetii (bacterium-to-cell ratio of 200:1). The cells were then infected with virulent bacteria as described for Fig. 1. Monocyte infection was determined at day 0 (A) and at 3 and 6 days p.i. (B) by Gimenez staining. In panel A, results (means ± SEs) are expressed as an infection index; in panel B, they are expressed as a relative infection index compared to values at day 0. ∗, P < 0.02; ∗∗, P < 0.01 (for the comparison of active patient values with control values).

C. burnetii stimulates cytokine overproduction in patient monocytes.We previously found that patients with Q fever endocarditis exhibit an increase in spontaneous TNF production by monocytes (5). We investigated C. burnetii-stimulated production of TNF in monocytes from controls and patients. The expression of cytokine transcripts was studied by using a quantitative method (Table 2). In the absence of C. burnetii, the amounts of TNF mRNA were significantly higher in active patients than in controls (P < 0.05). After 3 h of stimulation with C. burnetii at a bacterium-to-cell ratio of 200:1, TNF transcripts dramatically increased, but their levels were significantly higher in active patients than in controls (P < 0.01). In cured patients, the amounts of TNF transcripts, spontaneously produced or induced by C. burnetii, were near the control values. Cytokine secretion was assessed in supernatants from monocytes stimulated with C. burnetii for 24 h (Table 2). Monocytes from active patients spontaneously released more TNF than those from controls (P < 0.01). When monocytes were stimulated with C. burnetii, the levels of secreted TNF were higher in active patients than in controls (P < 0.04). The TNF release by monocytes stimulated or not stimulated byC. burnetii returned to normal values in patients who had recovered from the disease. The increase in C. burnetii-stimulated TNF production was specific, since the amounts of IL-6 transcripts were similar in unstimulated monocytes from active patients (142 ± 31 copies per ng of RNA) and controls (175 ± 27 copies per ng of RNA). Active patients and controls expressed IL-6 transcripts in response to C. burnetii in a similar way (437 ± 25 and 518 ± 50 copies per ng of RNA, respectively). No difference was observed between spontaneous and C. burnetii-induced releases of IL-6 in active patients and controls (142 ± 31 versus 175 ± 27 pg/ml and 437 ± 25 versus 518 ± 50 pg/ml, respectively). Taken together, our data indicate that defective elimination of C. burnetii in patients with active endocarditis is associated with a specific increase in TNF production.

View this table:
  • View inline
  • View popup
Table 2.

TNF production in Q fever endocarditisa

TNF is involved in defective killing of C. burnetii by patient monocytes.The role of TNF in impaired killing of C. burnetii was assessed by using neutralizing anti-TNF Ab, which completely inhibited C. burnetii-stimulated TNF secretion at 10 μg/ml (data not shown). First, monocyte supernatants from active patients were pretreated with anti-TNF Ab (or goat IgG) and then added to control monocytes before C. burnetii infection. The increase in bacterial phagocytosis and bacterial number at 3 and 6 days p.i. was prevented (data not shown). Second, anti-TNF Ab or control IgG was added to patient monocytes before the infection with C. burnetii. In active patients, 10 μg of anti-TNF Ab per ml decreased the uptake of C. burnetii by 36% ± 5% (Fig. 3A). The blocking Ab did not affect the bacterial number at 3 and 6 days p.i. in active patients or in cured patients (Fig. 3B). These results indicate that TNF in involved in defective killing of C. burnetii during Q fever endocarditis by acting mainly on bacterial uptake.

Fig. 3.
  • Open in new tab
  • Download powerpoint
Fig. 3.

Effect of anti-TNF Ab on C. burnetii killing. Monocytes from active (n = 5) and cured (n = 5) patients were incubated with C. burnetii in the presence of anti-TNF neutralizing Ab or control IgG (10 μg/ml) at day 0 (A), and monocyte infection was monitored for 3 and 6 days (B) at 37°C. Monocyte infection was determined as described for Fig. 1. In panel A, results (means ± SEs) are expressed as an infection index; in panel B, they are expressed as a relative infection index compared to values at day 0. ∗, P < 0.02 (for the comparison of values in the presence of anti-TNF Ab with values in the presence of control IgG).

DISCUSSION

In this study, we found that monocytes from patients with Q fever endocarditis were unable to eliminate C. burnetii, in contrast to control monocytes. This finding is complementary with early observations of immune dysfunction in Q fever, in which monocytes from patients with endocarditis are involved in the suppression of T-cell-mediated responses (18). This defect was a consequence of the activity of Q fever, since it was corrected in patients who had recovered from infection. It did not result from a generalized deficiency of bacterial killing, since patient monocytes eliminated avirulent C. burnetii and Legionella pneumophila (data not shown). This finding is reminiscent of data obtained for leprosy, in which monocytes of lepromatous leprosy patients support the growth of Mycobacterium leprae but restrict the multiplication of other bacteria susceptible to intracellular killing (15). The monocyte defect in C. burnetii killing affected early and delayed steps of microbicidal activity. C. burnetii uptake was significantly higher in monocytes from active patients than in monocytes from controls and cured patients. This finding may be related to the finding by Chaturvedi and Newman that a low growth of Mycobacterium avium or Histoplasma capsulatum is associated with a low phagocytosis by macrophages in human immunodeficiency virus-infected patients (9). However, the relationship between initial and delayed steps of bacterial killing is complex. Alveolar macrophages, which ingest more mycobacteria than monocytes, support a less efficient replication (13). The H37Ra and H37Rv strains of Mycobacterium tuberculosis are similar in their capacities to enter human macrophages, but they exhibit distinct survival patterns (27, 28). Our results show that the delayed step of microbicidal activity against C. burnetiiwas altered in monocytes from patients with Q fever endocarditis. This step of bacterial killing involves oxidative and nonoxidative mechanisms. The generation of reactive oxygen intermediates is apparently not required for C. burnetii killing. Indeed, monocyte production of reactive oxygen intermediates was similar in patients and healthy controls (data not shown). In addition, we showed that monocytes from patients with chronic granulomatous disease, which are known to be unable to produce reactive oxygen intermediates, eliminated C. burnetii as did control cells (10). It is likely that nonoxidative mechanisms such as intracellular traffic and vacuole environment (12) are modified in monocytes during Q fever endocarditis. The efficiency of chloroquine, which is known to alkalinize phagosomes, in Q fever treatment (24) supports this hypothesis.

The defect in C. burnetii killing by patient monocytes might be related to our experimental procedure, which was based on the culture of monocytes in the absence of lymphocytes. The coculture of monocytes with autologous lymphocytes did not restore C. burnetii killing of patient monocytes (data not shown). The defect in C. burnetii killing was not intrinsic, since it was reproduced by monocyte supernatants from patients with ongoing Q fever endocarditis. Thus, soluble mediators may be responsible for the lack of C. burnetii killing by monocytes. We provided evidence that TNF is largely involved in this defect. First, monocytes from patients with ongoing endocarditis, which were not competent to eliminate C. burnetii, overexpressed TNF transcripts and secreted high levels of TNF in response to C. burnetii. The TNF production by monocytes from cured patients, which efficiently killed bacteria, was similar to that by control monocytes. These results may be related to the increase in spontaneous production of TNF by monocytes from patients with ongoing endocarditis (5). Second, the treatment of monocyte supernatants with anti-TNF Ab abrogated their ability to promote C. burnetii survival in monocytes. The effect of TNF on C. burnetii survival is distinct from the usual role of TNF in containment of intracellular microorganisms (16). For instance, strains of M. tuberculosis recently characterized as having increased virulence elicited higher TNF levels than classical mycobacterial strains, but all of the strains grew in human monocytes at similar rates (19). However, IFN-γ, which stimulates TNF expression in macrophages, causes increased growth of M. tuberculosis in human cells (26). The multiplication of virulent strains ofM. tuberculosis in monocytes has been related to the production of TNF (27). We suggest that the ability ofC. burnetii to stimulate TNF production may serve primarily to promote pathogenesis rather than protection. On the other hand, TNF most probably affects the early phase of the C. burnetiikilling process. Indeed, blocking secreted TNF with anti-TNF Ab decreased bacterial uptake by monocytes of patients with ongoing endocarditis, but it did not enable monocytes to kill C. burnetii. Thus, it is likely that other factors related to monocyte activation interfere with delayed phases of C. burnetii killing. IFN-γ alone is not a good candidate, since its addition to patient monocytes infected with C. burnetii did not correct the deficiency in bacterial killing (data not shown).

We found that ongoing Q fever endocarditis is characterized by a deficiency of intracellular killing of C. burnetii by monocytes. This defect is largely corrected in cured patients. It is not intrinsic but involves secreted TNF. The secreted TNF primarily affects C. burnetii uptake but not delayed steps of intracellular killing. This finding assigns a role in pathogenesis of Q fever endocarditis to TNF and monocyte activation.

Notes

Editor: E. I. Tuomanen

FOOTNOTES

    • Received 22 July 1999.
    • Returned for modification 1 September 1999.
    • Accepted 5 October 1999.
  • Copyright © 2000 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Baca O. G.,
    2. Paretsky D.
    Q fever and Coxiella burnetii: a model for host-parasite interaction.Microbiol. Rev.471983127149
    OpenUrlFREE Full Text
  2. 2.↵
    1. Bach E. A.,
    2. Aguet M.,
    3. Schreiber R. D.
    The IFNγ receptor: a paradigm for cytokine receptor signaling.Annu. Rev. Immunol.151997563591
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Bläuer F.,
    2. Groscurth P.,
    3. Schneemann M.,
    4. Schoedon G.,
    5. Schaffner A.
    Modulation of the antilisterial activity of human blood-derived macrophages by activating and deactivating cytokines.J. Interferon Cyt. Res.151995105114
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Brunet P.,
    2. Capo C.,
    3. Dellacasagrande J.,
    4. Thirion X.,
    5. Mege J. L.,
    6. Berland Y.
    IL-10 synthesis and secretion by peripheral blood mononuclear cells in haemodialysis patients.Nephrol. Dial. Transplant.13199817451751
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Capo C.,
    2. Zugun F.,
    3. Stein A.,
    4. Tardei G.,
    5. Lepidi H.,
    6. Raoult D.,
    7. Mege J. L.
    Upregulation of tumor necrosis factor alpha and interleukin-1β in Q fever endocarditis.Infect. Immun.64199616381642
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Capo C.,
    2. Zaffran Y.,
    3. Zugun F.,
    4. Houpikian P.,
    5. Raoult D.,
    6. Mege J. L.
    Production of interleukin-10 and transforming growth factor β by peripheral blood mononuclear cells in Q fever endocarditis.Infect. Immun.64199641434147
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Capo C.,
    2. Amirayan N.,
    3. Ghigo E.,
    4. Raoult D.,
    5. Mege J. L.
    Circulating cytokine balance and activation markers of leukocytes in Q fever.Clin. Exp. Immunol.1151999120123
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    Capo, C., F. P. Lindberg, S. Meconi, Y. Zaffran, G. Tardei, E. J. Brown, D. Raoult, and J. L. Mege.Subversion of monocyte functions by Coxiella burnetii: impairment of the cross-talk between αvβ3 integrin and CR3. J. Immunol., in press.
  9. 9.↵
    1. Chaturvedi S.,
    2. Newman S. L.
    Modulation of the effector function of human macrophages for Histoplasma capsulatum by HIV-1.J. Clin. Invest.6199714651474
    OpenUrl
  10. 10.↵
    1. Dellacasagrande J.,
    2. Capo C.,
    3. Raoult D.,
    4. Mege J. L.
    IFN-γ-mediated control of Coxiella burnetii survival in monocytes. The role of cell apoptosis and TNF.J. Immunol.162199922592265
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Fournier P. E.,
    2. Casalta J. P.,
    3. Habib G.,
    4. Messana T.,
    5. Raoult D.
    Modification of the diagnostic criteria proposed by the Duke endocarditis service to permit improved diagnosis of Q fever endocarditis.Am. J. Med.1001996629633
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Heinzen R. A.,
    2. Scidmore M. A.,
    3. Rockey D. D.,
    4. Hackstadt T.
    Differential interaction with endocytic and exocytic pathways distinguish parasitophorous vacuoles of Coxiella burnetii and Chlamydia trachomatis.Infect. Immun.641996796809
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Hirsch C. S.,
    2. Ellner J. J.,
    3. Russel D. G.,
    4. Rich E. A.
    Complement receptor-mediated uptake and tumor necrosis factor-α-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages.J. Immunol.1521992743753
    OpenUrlAbstract
  14. 14.↵
    1. Izzo A. A.,
    2. Marmion B. P.
    Variation in interferon-gamma responses to Coxiella burnetii antigens with lymphocytes from vaccinated and naturally infected subjects.Clin. Exp. Immunol.941993507915
    OpenUrlPubMedWeb of Science
  15. 15.↵
    1. Kaplan G.,
    2. Hancock G. E.
    Macrophages in leprosy Human monocytes. Zembala M., Asherson G. L. 1989 459 468 Academic Press London, United Kingdom
  16. 16.↵
    1. Kaufmann S. H. E.
    Immunity to intracellular bacteria.Annu. Rev. Immunol.111993129163
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Koster F. T.,
    2. Williams J. C.,
    3. Goodwin J. S.
    Cellular immunity in Q fever: specific lymphocyte unresponsiveness in Q fever endocarditis.J. Infect. Dis.152198512831289
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Koster F. T.,
    2. Williams J. C.,
    3. Goodwin J. S.
    Cellular immunity in Q fever: modulation of responsiveness by a suppressor T cell-monocyte circuit.J. Immunol.135198510671072
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Manca C.,
    2. Tsenova L.,
    3. Barry C. E.,
    4. Bergtold A.,
    5. Freeman S.,
    6. Haslett P. A. J.,
    7. Musser J. M.,
    8. Freedman V. H.,
    9. Kaplan G.
    Mycobacterium tuberculosis CDC 1551 induces a more vigorous response in vivo and in vitro, but is not more virulent than other clinical isolates.J. Immunol.162199967406746
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Meconi S.,
    2. Jacomo V.,
    3. Boquet P.,
    4. Raoult D.,
    5. Mege J. L.,
    6. Capo C.
    Coxiella burnetii reorganization of the actin cytoskeleton in human monocytes.Infect. Immun.66199855275533
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Raoult D.
    Host factors in the severity of Q fever.Ann. N.Y. Acad. Sci.59019903338
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Raoult D.
    Treatment of Q fever.Antimicrob. Agents Chemother.37199317331736
    OpenUrlFREE Full Text
  23. 23.↵
    1. Raoult D.,
    2. Marrie T. J.
    Q fever.Clin. Infect. Dis.201995489496
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Raoult D.,
    2. Houpikian P.,
    3. Tissot Dupont H.,
    4. Riss J. M.,
    5. Arditi-Djiane J.,
    6. Brouqui P.
    Treatment of Q fever endocarditis: comparison of two regimens containing doxycycline and ofloxacin or hydroxychloroquine.Arch. Int. Med.1591999167173
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Rook G. A. W.
    Intracellular killing of microorganisms Human monocytes. Zembala M., Asherson G. L. 1989 291 302 Academic Press London, United Kingdom
  26. 26.↵
    1. Rook G. A. W.,
    2. Bloom B. R.
    Mechanisms of pathogenesis in tuberculosis Tuberculosis. Bloom B. R. 1994 485 501 ASM Press Washington, D.C.
  27. 27.↵
    1. Silver R. F.,
    2. Li Q.,
    3. Ellner J. J.
    Expression of virulence of Mycobacterium tuberculosis within human monocytes: virulence correlates with intracellular growth and induction of tumor necrosis factor alpha but not with evasion of lymphocyte-dependent monocyte effector functions.Infect. Immun.66199811901199
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Zhang M.,
    2. Gong J.,
    3. Lin Y.,
    4. Barnes P. F.
    Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages.Infect. Immun.661998794799
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Coxiella burnetii Survives in Monocytes from Patients with Q Fever Endocarditis: Involvement of Tumor Necrosis Factor
Jérôme Dellacasagrande, Eric Ghigo, Christian Capo, Didier Raoult, Jean-Louis Mege
Infection and Immunity Jan 2000, 68 (1) 160-164; DOI: 10.1128/IAI.68.1.160-164.2000

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Infection and Immunity article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Coxiella burnetii Survives in Monocytes from Patients with Q Fever Endocarditis: Involvement of Tumor Necrosis Factor
(Your Name) has forwarded a page to you from Infection and Immunity
(Your Name) thought you would be interested in this article in Infection and Immunity.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Coxiella burnetii Survives in Monocytes from Patients with Q Fever Endocarditis: Involvement of Tumor Necrosis Factor
Jérôme Dellacasagrande, Eric Ghigo, Christian Capo, Didier Raoult, Jean-Louis Mege
Infection and Immunity Jan 2000, 68 (1) 160-164; DOI: 10.1128/IAI.68.1.160-164.2000
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Notes
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Coxiella burnetii
Endocarditis, Bacterial
monocytes
Q fever
Tumor Necrosis Factor-alpha

Related Articles

Cited By...

About

  • About IAI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #IAIjournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0019-9567; Online ISSN: 1098-5522